Aditxt (ADTX) Competitors $0.49 -0.04 (-7.55%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ADTX vs. NCNA, CNSP, ONCT, XCUR, BFRI, GHSI, PCSA, SNPX, FRTX, and ATNFShould you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include NuCana (NCNA), CNS Pharmaceuticals (CNSP), Oncternal Therapeutics (ONCT), Exicure (XCUR), Biofrontera (BFRI), Guardion Health Sciences (GHSI), Processa Pharmaceuticals (PCSA), Synaptogenix (SNPX), Fresh Tracks Therapeutics (FRTX), and 180 Life Sciences (ATNF). These companies are all part of the "pharmaceutical products" industry. Aditxt vs. NuCana CNS Pharmaceuticals Oncternal Therapeutics Exicure Biofrontera Guardion Health Sciences Processa Pharmaceuticals Synaptogenix Fresh Tracks Therapeutics 180 Life Sciences Aditxt (NASDAQ:ADTX) and NuCana (NASDAQ:NCNA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, community ranking, profitability, valuation and analyst recommendations. Does the media prefer ADTX or NCNA? In the previous week, Aditxt had 1 more articles in the media than NuCana. MarketBeat recorded 1 mentions for Aditxt and 0 mentions for NuCana. Aditxt's average media sentiment score of 0.00 equaled NuCana'saverage media sentiment score. Company Overall Sentiment Aditxt Neutral NuCana Neutral Does the MarketBeat Community favor ADTX or NCNA? NuCana received 247 more outperform votes than Aditxt when rated by MarketBeat users. Likewise, 67.65% of users gave NuCana an outperform vote while only 44.44% of users gave Aditxt an outperform vote. CompanyUnderperformOutperformAditxtOutperform Votes444.44% Underperform Votes555.56% NuCanaOutperform Votes25167.65% Underperform Votes12032.35% Is ADTX or NCNA more profitable? NuCana's return on equity of -222.73% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets AditxtN/A -615.43% -157.59% NuCana N/A -222.73%-105.62% Do analysts recommend ADTX or NCNA? NuCana has a consensus price target of $25.00, indicating a potential upside of 1,512.90%. Given NuCana's higher possible upside, analysts clearly believe NuCana is more favorable than Aditxt.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aditxt 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ANuCana 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals & insiders have more ownership in ADTX or NCNA? 15.5% of Aditxt shares are owned by institutional investors. Comparatively, 44.0% of NuCana shares are owned by institutional investors. 1.7% of Aditxt shares are owned by company insiders. Comparatively, 31.2% of NuCana shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings and valuation, ADTX or NCNA? Aditxt has higher revenue and earnings than NuCana. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAditxt$640K3.23-$32.38MN/AN/ANuCanaN/AN/A-$34.37M-$12.20-0.13 Which has more volatility & risk, ADTX or NCNA? Aditxt has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, NuCana has a beta of 1.03, meaning that its stock price is 3% more volatile than the S&P 500. SummaryNuCana beats Aditxt on 8 of the 12 factors compared between the two stocks. Ad Porter & CompanyThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you. Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADTX vs. The Competition Export to ExcelMetricAditxtPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.07M$6.75B$5.04B$8.43BDividend YieldN/A7.94%7.52%4.16%P/E RatioN/A12.17130.2316.67Price / Sales3.23270.431,720.2276.26Price / CashN/A46.0936.9133.54Price / Book0.005.284.604.98Net Income-$32.38M$151.33M$114.94M$224.26M7 Day Performance-31.47%0.30%0.14%1.65%1 Month Performance-69.38%14.88%10.15%6.92%1 Year Performance-99.81%36.87%33.87%26.46% Aditxt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADTXAditxt0.1501 of 5 stars$0.49-7.5%N/A-99.8%$2.07M$640,000.000.0047Gap DownHigh Trading VolumeNCNANuCana3.0546 of 5 stars$1.75-0.6%$25.00+1,328.6%-86.9%$4.63MN/A-0.1430Positive NewsCNSPCNS Pharmaceuticals1.2799 of 5 stars$0.14-5.6%$0.50+265.2%-99.9%$4.58MN/A0.005Gap UpONCTOncternal Therapeutics2.4467 of 5 stars$1.53+6.6%$20.00+1,207.2%-79.2%$4.53M$790,000.00-0.1330Analyst ForecastHigh Trading VolumeXCURExicure2.3529 of 5 stars$2.58+7.1%N/A+401.6%$4.46M$28.83M-0.5750BFRIBiofrontera2.3851 of 5 stars$0.88-1.6%$7.00+699.1%-75.5%$4.46M$35.24M-0.1570GHSIGuardion Health Sciences1.6271 of 5 stars$3.29flatN/A-47.6%$4.44M$12.23M0.6810Upcoming EarningsGap DownPCSAProcessa Pharmaceuticals2.399 of 5 stars$1.35flat$6.00+344.4%-83.5%$4.40MN/A-0.3420Negative NewsSNPXSynaptogenix1.7233 of 5 stars$3.18-1.2%$14.00+340.3%-60.8%$4.33MN/A0.004Gap DownFRTXFresh Tracks TherapeuticsN/A$0.72+1.4%N/A-18.9%$4.30M$8.01M-0.5120ATNF180 Life SciencesN/A$4.43+4.7%N/A-54.0%$4.17MN/A0.007Gap Up Related Companies and Tools Related Companies NuCana Alternatives CNS Pharmaceuticals Alternatives Oncternal Therapeutics Alternatives Exicure Alternatives Biofrontera Alternatives Guardion Health Sciences Alternatives Processa Pharmaceuticals Alternatives Synaptogenix Alternatives Fresh Tracks Therapeutics Alternatives 180 Life Sciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADTX) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
